期刊
BIOMEDICINES
卷 11, 期 1, 页码 -出版社
MDPI
DOI: 10.3390/biomedicines11010177
关键词
drug hypersensitivity; T lymphocytes; HLA; Stevens-Johnson syndrome; drug reaction with eosinophilia and systemic symptoms; severe cutaneous adverse reactions
Drug hypersensitivity reactions can be immediate or delayed. Delayed drug hypersensitivity is mainly caused by T lymphocyte recognition of drug antigens and cell activation. This type of hypersensitivity can have various clinical presentations ranging from mild reactions to severe cutaneous adverse reactions. Common culprits of delayed drug hypersensitivity include anti-epileptics, antibiotics, anti-gout agents, and anti-viral drugs. The pathogenesis involves molecular recognition, genetic susceptibility, and immune mediators.
Drug hypersensitivity reactions are classified into immediate and delayed types, according to the onset time. In contrast to the immediate type, delayed drug hypersensitivity mainly involves T lymphocyte recognition of the drug antigens and cell activation. The clinical presentations of such hypersensitivity are various and range from mild reactions (e.g., maculopapular exanthema (MPE) and fixed drug eruption (FDE)), to drug-induced liver injury (DILI) and severe cutaneous adverse reactions (SCARs) (e.g., Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP)). The common culprits of delayed drug hypersensitivity include anti-epileptics, antibiotics, anti-gout agents, anti-viral drugs, etc. Delayed drug hypersensitivity is proposed to be initiated by different models of molecular recognition, composed of drug/metabolite antigen and endogenous peptide, HLA presentation, and T cell receptor (TCR) interaction. Increasing the genetic variants of HLA loci and drug metabolic enzymes has been identified to be responsible for delayed drug hypersensitivity. Furthermore, preferential TCR clonotypes, and the activation of cytotoxic proteins/cytokines/chemokines, are also involved in the pathogenesis of delayed drug hypersensitivity. This review provides a summary of the current understanding of the molecular recognition, genetic susceptibility, and immune mediators of delayed drug hypersensitivity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据